InsiderSource
NUVL

Nuvalent, Inc.

SEC CIK 1861560
$123.39 +19.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$20.89M
52 open-market
Net insider flow
−$20.89M
Net selling
Filings shown
305
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at NUVL have sold a net $20.89M of stock (0 open-market buys vs 52 sells).

Largest recent trade: Flynn James E sold $97.75M of NUVL, trimming their stake 10%.

Most active filer: Miller Deborah Ann, with 124 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for NUVL, newest first
View on SEC EDGAR ↗
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed Apr 1, 2026 ΔOwn +9.5%
+$153.2K
5,500 sh @ $28
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Apr 1, 2026 ΔOwn −4.0%

Noci Darlene sold $246.7K of NUVL, trimming their stake 4%.

−$246.7K
2,532 sh @ $97
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Apr 1, 2026 ΔOwn −4.9%

Noci Darlene sold $291.2K of NUVL, trimming their stake 5%.

−$291.2K
2,968 sh @ $98
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 30, 2026 ΔOwn −1.4%

Miller Deborah Ann sold $91.7K of NUVL, trimming their stake 1%.

−$91.7K
940 sh @ $98
Advertisement
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 30, 2026 ΔOwn −2.7%

Miller Deborah Ann sold $172.6K of NUVL, trimming their stake 3%.

−$172.6K
1,757 sh @ $98
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 30, 2026 ΔOwn −4.5%

Miller Deborah Ann sold $278.8K of NUVL, trimming their stake 4%.

−$278.8K
2,803 sh @ $99
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −14%

Balcom Alexandra sold $1.37M of NUVL, trimming their stake 14%.

−$1.37M
13,700 sh @ $100
NUVL
Nuvalent, Inc.
Option exercise Balcom Alexandra · Chief Financial Officer · Option exercise · filed Mar 26, 2026 ΔOwn +12%
+$12.3K
11,430 sh @ $1
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −2.3%

Balcom Alexandra sold $247K of NUVL, trimming their stake 2%.

−$247K
2,599 sh @ $95
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −7.1%

Balcom Alexandra sold $735.5K of NUVL, trimming their stake 7%.

−$735.5K
7,671 sh @ $96
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −1.2%

Balcom Alexandra sold $111.9K of NUVL, trimming their stake 1%.

−$111.9K
1,160 sh @ $97
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −1.1%

Pelish Henry E. sold $78.7K of NUVL, trimming their stake 1%.

−$78.7K
804 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −3.7%

Pelish Henry E. sold $256.7K of NUVL, trimming their stake 4%.

−$256.7K
2,597 sh @ $99
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −2.5%

Pelish Henry E. sold $169.8K of NUVL, trimming their stake 3%.

−$169.8K
1,703 sh @ $100
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +10%
+$160.1K
8,456 sh @ $19
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +1.9%
+$48.8K
1,754 sh @ $28
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +4.4%
+$121K
4,125 sh @ $29
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +3.1%
+$216K
2,985 sh @ $72
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −24%

Pelish Henry E. sold $2.37M of NUVL, trimming their stake 24%.

−$2.37M
24,189 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −7.2%

Pelish Henry E. sold $541.9K of NUVL, trimming their stake 7%.

−$541.9K
5,505 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −0.4%

Pelish Henry E. sold $30.3K of NUVL.

−$30.3K
306 sh @ $99
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Mar 10, 2026 ΔOwn −3.8%

Porter James Richard sold $1.34M of NUVL, trimming their stake 4%.

−$1.34M
13,585 sh @ $99
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Mar 10, 2026 ΔOwn −4.7%

Porter James Richard sold $1.59M of NUVL, trimming their stake 5%.

−$1.59M
16,015 sh @ $99
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Mar 10, 2026 ΔOwn −0.1%

Porter James Richard sold $40.1K of NUVL.

−$40.1K
400 sh @ $100
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed Mar 2, 2026 ΔOwn +9.5%
+$153.2K
5,500 sh @ $28
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −4.7%

Noci Darlene sold $307.9K of NUVL, trimming their stake 5%.

−$307.9K
3,000 sh @ $103
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −3.8%

Noci Darlene sold $237.9K of NUVL, trimming their stake 4%.

−$237.9K
2,300 sh @ $103
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −0.3%

Noci Darlene sold $20.9K of NUVL.

−$20.9K
200 sh @ $104
Advertisement

About NUVL insider activity

This page tracks every recent Form 4 filed for Nuvalent, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is NUVL insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Nuvalent, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.